Physician profile
Samuel Serna
NPI 1568596559
$738.53
in general payments reported to CMS, 2019-2025
12 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.67 · 2022: $20.74 · 2024: $484 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $225.98 | 2024 | |
| Boston Scientific Corporation | $116.58 | 2024-2025 | Embold Fibered, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Bard Peripheral Vascular, INC. | $81.01 | 2019 | |
| Cardiva Medical, INC. | $73.42 | 2024 | Cardiva Vascade 6/7f Vcs |
| Inari Medical, INC. | $48.25 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $47.07 | 2025 | Indigo System |
| Becton, Dickinson and Company | $41.11 | 2024 | Duoglide Catheter, Bd Nexiva Diffusics |
| Stryker Corporation | $25.92 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merit Medical Systems INC | $23.27 | 2025 | Wrapsody Stent Graft, Surfacer Inside-Out Catheter |
| Eisai INC. | $22.52 | 2024 | |
| Terumo Medical Corporation | $20.74 | 2022 | |
| Biogen, INC. | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Serna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.